CLINICAL_TRIALS
trial_result
· 2014-12-30
Clinical Trial Update: Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism [Phase 3]
Summary
A Phase 3 trial evaluating long-term treatment with testosterone undecanoate in males with hypogonadism has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Hypogonadism | Phase 3 | Status: COMPLETED